Status:
COMPLETED
Procedural Sedation for Pediatric Patients With Spinal Muscular Atrophy
Lead Sponsor:
Ankara City Hospital Bilkent
Conditions:
Muscular Atrophy, Spinal
Child, Only
Eligibility:
All Genders
Up to 18 years
Brief Summary
Background and Aim: Spinal muscular atrophy (SMA) is a neuromuscular disease characterized by progressive symmetrical weakness and atrophy of proximal muscles causing from degeneration of anterior hor...
Detailed Description
Design: This research is a retrospective obsevational study. Methods: After approval Institutional Review Board, data from anesthesia charts and electronic medical records of 14 patients with SMA type...
Eligibility Criteria
Inclusion
- Pediatric patients younger than 18 years old with SMA 1,2 and 3 who were to undergo intrathecal Nusinersen treatment were included in this study.
Exclusion
- Patients whose procedures were performed under fluoroscopic guidance in the radiology unit were excluded from the study because their procedures were performed in another hospital.
- Patients without a diagnosis of SMA
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 31 2022
Estimated Enrollment :
14 Patients enrolled
Trial Details
Trial ID
NCT05291962
Start Date
January 1 2022
End Date
January 31 2022
Last Update
March 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Feyza Sever
Ankara, Çankaya, Turkey (Türkiye), 06800